Xenon Pharmaceuticals Inc. (XENE) has 66 open-market insider trades by 24 insiders since 2015. Over the last six months insiders net bought $1.0M. The most active filer is Simon N. Pimstone, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Simon N. Pimstone | Dir | — | 9 | $25.1M | 2023-06-01 |
| Ian Mortimer | CEOPres | — | 7 | $23.0M | 2026-09-30 |
| James R. Empfield | VP | — | 3 | $6.7M | 2022-08-12 |
| Sherrington Robin | VP | — | 4 | $6.7M | 2024-03-07 |
| Sherry Aulin | CFO | — | 2 | $2.8M | 2024-12-18 |
| BVF Partners L P/il | 10% Owner | — | 2 | $2.3M | 2017-06-19 |
| Gary Patou | Dir | — | 6 | $2.3M | 2026-06-05 |
| Dawn Svoronos | Dir | — | 2 | $2.1M | 2026-06-01 |
| Steven Gannon | Dir | — | 4 | $1.3M | 2026-08-11 |
| Frank A. Holler | Dir | — | 6 | $1.3M | 2021-05-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Thomas Patrick Kelly | CFO | Buy | $560K | 2026-09-30 |
| Ian Mortimer | CEO & President | Buy | $1.1M | 2026-09-30 |
| Christopher John Kenney | — | Sell | $426K | 2026-08-28 |
| Steven Gannon | Director | Sell | $641K | 2026-08-11 |
| Gillian Cannon | Director | Sell | $63K | 2026-06-05 |
| Gary Patou | Director | Sell | $70K | 2026-06-05 |
Companies that share insiders with XENE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ian Mortimer | President | Sell | $404K | 2026-03-13 |
| Christopher John Kenney | Chief Medical Officer | Sell | $78K | 2026-03-13 |
| Andrea DiFabio | CLO | Sell | $74K | 2026-03-13 |
| Andrea DiFabio | CLO | Sell | $157K | 2026-03-10 |
| Christopher John Kenney | — | Sell | $167K | 2026-03-10 |
| Ian Mortimer | CEO & President | Sell | $17.0M | 2026-03-09 |
| Ian Mortimer | CEO & President | Sell | $1.8M | 2026-01-02 |
| Ian Mortimer | CEO & President | Sell | $2.3M | 2025-12-05 |
| Ian Mortimer | President | Sell | $4K | 2025-11-28 |